Fluorescence microscopy analysis indicated that the EGFR aptamer-functionalized nanoparticles effectively targeted lung cancer cells (A549 and NCI-H226) over normal lung cells (Beas2B). The gene discussed is EGFR; the disease is lung carcinoma.